288 related articles for article (PubMed ID: 35484367)
21. On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era.
Busschots D; Bielen R; Koc ÖM; Heyens L; Dercon E; Verrando R; Janssens F; Van den Bergh L; Van Lint P; Bruckers L; Nevens F; Robaeys G
BMC Public Health; 2021 Aug; 21(1):1574. PubMed ID: 34416867
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C.
Martinello M; Solomon SS; Terrault NA; Dore GJ
Lancet; 2023 Sep; 402(10407):1085-1096. PubMed ID: 37741678
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy as an Opportunity for Hepatitis C Virus Elimination and Eradication.
Boudova S; Tholey D; Fenkel JM; Derman R; Boelig RC
Am J Trop Med Hyg; 2024 Feb; 110(2):199-201. PubMed ID: 38150734
[TBL] [Abstract][Full Text] [Related]
24. Prescribing direct-acting antivirals to treat hepatitis C virus in a general practice setting in Australia: 'so why not do it'?
Heard E; Massi L; Smirnov A; Selvey LA
Intern Med J; 2020 Sep; 50(9):1053-1058. PubMed ID: 31589351
[TBL] [Abstract][Full Text] [Related]
25. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
[TBL] [Abstract][Full Text] [Related]
26. Can Telementoring Reduce Urban-Rural Disparities in Utilization of Direct-Acting Antiviral Agents?
Du P; Wang X; Kong L; Jung J
Telemed J E Health; 2021 May; 27(5):488-494. PubMed ID: 32882154
[No Abstract] [Full Text] [Related]
27. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers.
Kapadia SN; Marks KM
Clin Ther; 2018 Aug; 40(8):1234-1245. PubMed ID: 29983266
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.
Guss D; Sherigar J; Rosen P; Mohanty SR
J Gen Intern Med; 2018 Apr; 33(4):551-557. PubMed ID: 29352420
[TBL] [Abstract][Full Text] [Related]
30. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
Jonas MC; Loftus B; Horberg MA
Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus micro-elimination within a clinic for people with HIV: challenges in the home stretch.
Hanna J; Sufian J; Suh JS; Jimenez HR
HIV Med; 2022 Aug; 23(7):801-806. PubMed ID: 35150183
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings.
Ngo BV; James JR; Blalock KL; Jackson SL; Chew LD; Tsui JI
J Subst Abuse Treat; 2021 Dec; 131():108438. PubMed ID: 34098298
[TBL] [Abstract][Full Text] [Related]
33. The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017-2019 Mass Screening and Treatment Campaign.
Nisingizwe MP; Makuza JD; Janjua NZ; Bansback N; Hedt-Gauthier B; Serumondo J; Remera E; Law MR
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992370
[TBL] [Abstract][Full Text] [Related]
34. Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis.
Yousafzai MT; Bajis S; Alavi M; Grebely J; Dore GJ; Hajarizadeh B
J Viral Hepat; 2021 Oct; 28(10):1340-1354. PubMed ID: 34310812
[TBL] [Abstract][Full Text] [Related]
35. Chronic Hepatitis C Cascade of Care in Prisoners-Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy.
Cambianica A; Marchese V; Pennati F; Faustinelli A; Migliorati M; Roda F; Spinetti A; Zaltron S; Fiorentini S; Caruso A; Quiros-Roldan E; Castelli F; Focà E
Int J Environ Res Public Health; 2024 Jan; 21(1):. PubMed ID: 38248566
[TBL] [Abstract][Full Text] [Related]
36. Strategy for the Elimination of Hepatitis C in Cantabria.
Crespo J; Tejerina Puente A; Cuadrado A; Llerena S; Cabezas J;
Rev Esp Enferm Dig; 2020 Jul; 112(7):565-570. PubMed ID: 32543873
[TBL] [Abstract][Full Text] [Related]
37. Microbiota and hepatitis C virus in the era of direct-acting antiviral agents.
Pinchera B; Moriello NS; Buonomo AR; Zappulo E; Viceconte G; Villari R; Gentile I
Microb Pathog; 2023 Feb; 175():105968. PubMed ID: 36626945
[TBL] [Abstract][Full Text] [Related]
38. When Coadministration Cannot Be Avoided: Real World Experience of Direct Acting Antivirals for the Treatment of Hepatitis C Virus Infection in Patients on First Generation Anticonvulsants.
Natali KM; Jimenez HR; Slim J
J Pharm Pract; 2022 Jun; 35(3):495-499. PubMed ID: 33317381
[TBL] [Abstract][Full Text] [Related]
39. Acute searching and early diagnosis of HCV infected persons.
Husa Ml P; Husa P
Vnitr Lek; 2021; 67(8):455-458. PubMed ID: 35459364
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C: Standard of Treatment and What to Do for Global Elimination.
Di Marco L; La Mantia C; Di Marco V
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
